Avatrombopag in immune thrombocytopenia: A real‐world study of the Spanish ITP Group (GEPTI)
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27498 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Cristina Pascual-Izquierdo und 36 weiteren Autor:innen. Beteiligte Einrichtung: Hospital General Universitario Gregorio Marañón, Madrid, Spain. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Receptors, Thrombopoietin. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Avatrombopag is the newest thrombopoietin receptor agonist (TPO‐RA) approved to treat immune thrombocytopenia (ITP). Real‐world evidence regarding effectiveness/safety is limited. The Spanish ITP Group (GEPTI) performed a retrospective study with patients starting avatrombopag for the first time. A total of 268 ITP patients were recruited. The median (interquartile range [IQR]) follow‐up time was 47.5 (30.4–58.9) weeks. Among the 193 patients with baseline platelet counts
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital General Universitario Gregorio Marañón, Madrid, Spain.
- Instituto de Investigación Gregorio Marañón, Madrid, Spain.
- Hospital del Mar, Barcelona, Spain.
- Hospital Universitario Son Espases, Palma de Mallorca, Spain.
- Hospital Universitario Virgen Macarena, Sevilla, Spain.
- Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
ORCID-Profile: Cristina Pascual-Izquierdo, María-Teresa Álvarez-Román, Gonzalo Caballero-Navarro
Zitieren
APA
Pascual-Izquierdo, C., Sánchez-González, B., Canaro-Hirnyk, M. I., García-Donas, G., Menor-Gómez, M., Gil-Fernández, J. J., Monsalvo-Saornil, S., de-Laiglesia, A., Álvarez-Román, M. T., Jarque-Ramos, I., Llácer, M. J., Pedrote-Amador, B., Zafra-Torres, D., Caparrós-Miranda, I., Ortúzar-Pasalodos, A., Revilla-Calvo, N., Bastida, J. M., Chica-Gullón, E., Alvarellos, M., …, & Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) (2024). Avatrombopag in immune thrombocytopenia: A real‐world study of the Spanish ITP Group (GEPTI). American Journal of Hematology. https://doi.org/10.1002/ajh.27498
Vancouver
Pascual-Izquierdo C, Sánchez-González B, Canaro-Hirnyk MI, García-Donas G, Menor-Gómez M, Gil-Fernández JJ, et al. Avatrombopag in immune thrombocytopenia: A real‐world study of the Spanish ITP Group (GEPTI). American Journal of Hematology. 2024. doi:10.1002/ajh.27498
BibTeX
@article{PascualIzquierdo2024,
author = {Pascual-Izquierdo, Cristina and Sánchez-González, Blanca and Canaro-Hirnyk, Mariana-Isabel and García-Donas, Gloria and Menor-Gómez, María and Gil-Fernández, Juan-José and Monsalvo-Saornil, Silvia and de-Laiglesia, Almudena and Álvarez-Román, María-Teresa and Jarque-Ramos, Isidro and Llácer, María-José and Pedrote-Amador, Begoña and Zafra-Torres, Denis and Caparrós-Miranda, Isabel and Ortúzar-Pasalodos, Ariana and Revilla-Calvo, Nuria and Bastida, José-María and Chica-Gullón, Esther and Alvarellos, Montserrat and Jiménez-Bárcenas, Reyes and Bernat, Silvia and Martínez-Carballeira, Daniel and Lakhwani, Sunil and López-Ansoar, Elsa and Moreno-Beltrán, María-Esperanza and Lorenzo-Vizcaya, Álvaro and Aguirre, María-Aránzazu and Lasa-Eguialde, Maialen and Canet, Marta and González-Gascón-Y-Marín, Isabel-Teresa and Caballero-Navarro, Gonzalo and Cuesta, Amalia and Díaz-López, Marta and Arquero, Teresa and Moreno-Carbonell, Marta and Mingot-Castellano, María-Eva and Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH), Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH)},
title = {Avatrombopag in immune thrombocytopenia: A real‐world study of the Spanish ITP Group (GEPTI)},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27498}
}
EUVIMED